Rosuvastatin Again Linked With Risks to Kidneys : vimarsana.

Practice should more often heed FDA-recommended rosuvastatin dosages for patients with severe chronic kidney disease and step up monitoring for renal safety in such cases, experts say.

Related Keywords

Maryland , United States , Canada , Ottawa , Ontario , Baltimore , American , Swapnil Hiremath , Journal Of The American Society Nephrology , Ottawa Hospital Research Institute , Johns Hopkins Bloomberg School Of Public Health , University Of Ottawa , American Society , Medical News , Johns Hopkins Bloomberg School , Public Health , Education Are , Freely Filtered , Practice Unclear , Optumlabs Data Warehouse , Chronic Renal Failure , Hronic Kidney Failure , Hronic Kidney Disease Ckd , Chronic Kidney Disease , Kd , Cv , Ardiovascular , Statin , Lipid Lowering Drugs , Rug Lipid Lowering , Kidneys , Lipids , Ipid Management , Hematuria , Proteinuria , Nephrotoxicity , Renal Disease , Kidney Disease , Kidney Disorder , Renal Disorder , Ephropathy , Adverse Effects , Side Effects , Patient Safety , Clinical Research , Clinical Trial ,